We are happy to announce that Thirona Retina entered a partnership with Finnish medical technology company Optomed , one of the leading providers of handheld fundus cameras. Optomed Aurora handheld camera will be now distributed together with our AI-assisted RetCAD software for retinal image analysis in Europe and selected Middle East and Asian countries. 

Optomed Aurora handheld fundus camera is a compact tool for screening of various eye diseases, such as diabetic retinopathy, AMD and glaucoma. Thanks to its easy-to-use concept, the camera can be used almost anywhere.

"We are excited to expand our presence to the handheld fundus camera market and make the innovation available to many more patients faster, together with Optomed.  We believe that our shared commitment to quality forms an excellent basis for a successful long-term partnership.", says Mark van Grinsven, Thirona Retina’s Managing Director. 

Optomed Vice President Devices, Laura Piila, comments: "We are enthusiastic to establish this partnership with Thirona Retina. Optomed and Thirona Retina have a shared and well-aligned vision of providing outstanding quality and usability with our solutions to help detect vision-threatening diseases early. RetCADTM integrated with Optomed Aurora provides a powerful tool with an optimized workflow for eye screening." 

We are looking forward to this collaboration, happy to see the footprint of AI-supported eye care growing, and ultimately helping more people around the world.